GSK's Advair up for dispute in Germany - FiercePharma
Links shared publicly online about this topic.
- 1,373total visits
GSK's Advair up for dispute in Germany - FiercePharma
View full resource at fiercepharma.com
Tags: Asthma, Asthma Medication, COPD Medication, Drug, Advair, GlaxoSmithKline
Most Recently Shared on February 18, 2010 at 4:24 pm By:
GSK's Advair up for dispute in Germany. http://bit.ly/cG6OqJ
In the News / EXCLUSIVE: Showtime has put in development The Angry Buddhist, a drama series project based on Seth Greenland’s of the same name. Novelist/playwright/screenwriter Greenland (HBO’s Big Love) will write the adaptation, from Anonymous Content.
pinterest.com — “In the News / EXCLUSIVE: Showtime has put in development The Angry Buddhist, a drama series project based on Seth Greenland’s of the same name. Novelist/playwright/screenwriter Greenland (HBO’s Big Love) will write the adaptation, from Anonymous Content. The drama with dark comedy elements is set in the high California desert. It centers on three brothers: a cop studying Buddhism, an unrepentant criminal and a wily U.S. Congressman running for his third term.” View full resource at pinterest.com
Most Recently Shared on April 18, 2012 at 12:34 am By:
http://t.co/r5ggjIKO EXCLUSIVE: Showtime has put in development @sethgreenland 's The Angry Buddhist. Greenland will write the adaptation.
Never Spend Money on Things That Don’t Add Value to Your Life « Carolyn Anderson – Motivational Speaker, Entrepreneur & Doctor
carolynandersonmd.com — “Everything you buy should be essential or something you absolutely love that adds value to your life. A worthwhile investment contributes to the support of your body, mind and spirit.” View full resource at carolynandersonmd.com
Most Recently Shared on April 3, 2012 at 10:15 pm By:
Impowerage. Mom to a 1.5 year old who enjoys staying active." /> Dr. Carolyn Anderson Active Health Library, Doctor, Surgeon, Ophthalmologist, and Physician
Never Spend Money on Things That Don’t Add Value to Your Life http://t.co/GSkE4QhU
GSK grant supports STEM education for NC students :: STEM Education at WRAL Tech Wire
wraltechwire.com — “North Carolina's growing network of innovative STEM schools is getting a boost from a three-year, $750,000 grant from GlaxoSmithKline.” View full resource at wraltechwire.com
Most Recently Shared on March 26, 2012 at 5:20 pm By:
PM RT @WRALTechWire: New blog post: GSK grant supports STEM education for NC students http://t.co/LuHsvlh0
Relovair COPD and asthma filings on track despite more mixed trial results - Pharmaceutical and Biotechnology News - Pharma Letter
thepharmaletter.com — “As well as announcing new mixed clinical trial data, UK pharma giant GlaxoSmithKline (LSE: GSK) and US partner Theravance (Nasdaq: THRX) say that the registrational program for their investigational drug Relovair (fluticasone furoate and vilanterol (FF/VI” View full resource at thepharmaletter.com
Most Recently Shared on March 26, 2012 at 12:02 pm By:
Michael Blaiss, MD Physician, Doctor, and Allergist
Relovair COPD and asthma filings on track despite more mixed trial results http://t.co/iccTfECw
The Alpha Parent: Forward Facing Car Seats - a no brainer
thealphaparent.com — “The snobby side of parenting” View full resource at thealphaparent.com
Most Recently Shared on March 23, 2012 at 9:27 pm By:
Sally Wits Parenting Supporter
RT @AlphaParent: Why You Should Use A Rear Facing Car Seat For As Long As Possible: http://t.co/84dGSkNu #parenting #childsafety #carseats
GSK, J&J Join Index Ventures' Asset-Based $199M VC Fund - Drugs.com MedNews
drugs.com — “From BioWorld Today (March 22, 2012) LONDON - Spring has arrived on cue for European biotech with the launch of a new 150 million (US 199 million) venture capit” View full resource at drugs.com
Most Recently Shared on March 23, 2012 at 7:06 pm By:
Drugs and Devices OW OW Health
GSK, J&J Join Index Ventures' Asset-Based $199M VC Fund: From BioWorld Today (March 22, 2012) LONDON - Spr... http://t.co/NGPRpqfy #drug
American Chemical Society - The world's largest scientific society.
abstracts.acs.org — “American Chemical Society - The world's largest scientific society.” View full resource at abstracts.acs.org
Most Recently Shared on March 23, 2012 at 3:13 pm By:
Lisa Jarvis Science Enthusiast
Look for @carmendrahl live blog on Sun on 1st disclosures: $GSK's PI3Kb inh, $BMY's CGRP antag & NS5b inh, http://t.co/2DGdgthO #ACSSanDiego
UPDATED: GSK, Theravance share mixed bag of lung drug data ahead of FDA filing - FierceBiotech
fiercebiotech.com — “GlaxoSmithKline ($GSK) and partner Theravance ($THRX) have dropped another up-and-down set of data related to development of their blockbuster hopeful Relovair today. Yet the duo remains on schedule Read more...” View full resource at fiercebiotech.com
Most Recently Shared on March 23, 2012 at 2:01 pm By:
GSK, Theravance share mixed bag of lung drug data ahead of FDA filing http://t.co/LgS62K4g $GSK $THRX #biotech #COPD
GSK lung drug has mixed results but filing on track - Yahoo! News
news.yahoo.com — “From Yahoo! News: LONDON (Reuters) - GlaxoSmithKline reiterated a plan to submit its key new lung drug Relovair for regulatory approval in mid-2012, despite releasing another batch of mixed clinical trial results on Friday. The new once-a-day inhaled medicine showed superiority to GSK's existing twice-daily drug Advair in one trial for chronic lung disease, but not another. That patchy record echoes results of other studies in an extensive development program. Britain's biggest drugmaker, howeve” View full resource at news.yahoo.com
Most Recently Shared on March 23, 2012 at 1:31 pm By:
HealthTrendster Health Executive
GSK lung drug has mixed results but filing on track - LONDON (Reuters) - GlaxoSmithKline reiterated a plan to submit... http://t.co/pn6eaUBd
GSK lung drug has mixed results but filing on track - Yahoo! News
news.yahoo.com — “From Yahoo! News: LONDON (Reuters) - GlaxoSmithKline reiterated a plan to submit its key new lung drug Relovair for regulatory approval in mid-2012, despite releasing another batch of mixed clinical trial results on Friday. The new once-a-day inhaled medicine showed superiority to GSK's existing twice-daily drug Advair in one trial for chronic lung disease, but not another. That patchy record echoes results of other studies in an extensive development program. Britain's biggest drugmaker, howeve” View full resource at news.yahoo.com
Most Recently Shared on March 23, 2012 at 1:23 pm By:
GSK lung drug has mixed results but filing on track: LONDON (Reuters) - GlaxoSmithKline reiterated a plan to sub... http://t.co/W4eIxzVS
GSK and Theravance Announce Completion of the Relovair Registrational Programme and Topline Results From Relovair Vs. Advair Phase III Studies in COPD - Drugs.com MedNews
drugs.com — “From GlobeNewswire (March 23, 2012) LONDON and SOUTH SAN FRANCISCO, Calif., March 23, 2012 (GLOBE GlaxoSmithKline (GSK) and Theravance, Inc. (Nasdaq THRX) today” View full resource at drugs.com
Most Recently Shared on March 23, 2012 at 1:07 pm By:
Drugs and Devices OW OW Health
GSK and Theravance Announce Completion of the Relovair Registrational Programme and Topline Results From R... http://t.co/nDItbEP6 #drug
GSK lung drug has mixed results but filing on track | Reuters
reuters.com — “LONDON (Reuters) - GlaxoSmithKline reiterated a plan to submit its key new lung drug Relovair for regulatory approval in mid-2012, despite releasing another batch of mixed clinical trial results on Friday.The” View full resource at reuters.com
Most Recently Shared on March 23, 2012 at 12:49 pm By:
Michael Blaiss, MD Physician, Doctor, and Allergist
GSK lung drug has mixed results but filing on track | Reuters http://t.co/0p296ID6
GSK lung drug has mixed results but filing on track | Reuters
reuters.com — “LONDON (Reuters) - GlaxoSmithKline reiterated a plan to submit its key new lung drug Relovair for regulatory approval in mid-2012, despite releasing another batch of mixed clinical trial results on Friday.The” View full resource at reuters.com
Most Recently Shared on March 23, 2012 at 12:47 pm By:
GSK lung drug has mixed results but filing on track http://t.co/OUnhBOCt
GSK lung drug has mixed results but filing on track | Reuters
reuters.com — “LONDON (Reuters) - GlaxoSmithKline reiterated a plan to submit its key new lung drug Relovair for regulatory approval in mid-2012, despite releasing another batch of mixed clinical trial results on Friday.The” View full resource at reuters.com
Most Recently Shared on March 23, 2012 at 12:44 pm By:
GSK lung drug has mixed results but filing on track: LONDON (Reuters) - GlaxoSmithKline reiterated a plan to sub... http://t.co/oiEWizpj
GSK lung drug has mixed results but filing on track | Reuters
reuters.com — “LONDON (Reuters) - GlaxoSmithKline reiterated a plan to submit its key new lung drug Relovair for regulatory approval in mid-2012, despite releasing another batch of mixed clinical trial results on Friday.The” View full resource at reuters.com
Most Recently Shared on March 23, 2012 at 12:44 pm By:
GSK lung drug has mixed results but filing on track http://t.co/5ehcHDri
Advertisement
